Literature DB >> 6106688

Aspirin binding and the effect of albumin on spontaneous and enzyme-catalysed hydrolysis.

L Aarons, P Clifton, G Fleming, M Rowland.   

Abstract

A method of measuring the binding of aspirin to albumin without the interference of hydrolysis was developed. At concentrations of 10 mg litre-1, aspirin is about 85% bound to bovine serum albumin (4 g %), whereas its hydrolysis product, salicylic acid, is 95% bound. Salicylic acid was shown to displace aspirin from albumin binding sites. Both salicylic acid and aspirin bind more strongly to bovine serum albumin than to human serum albumin at protein concentrations of 4 g %. Protein binding protected aspirin against spontaneous hydrolysis although protein-bound aspirin still hydrolysed at a finite rate. In contrast, albumin enhanced the enzyme-catalysed hydrolysis of aspirin. By using a simple model, the rate constants for the individual processes contributing to the overall hydrolysis rate constant in the presence of albumin and esterase are calculated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106688     DOI: 10.1111/j.2042-7158.1980.tb12991.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  11 in total

1.  In vitro amiodarone protein binding and its interaction with warfarin.

Authors:  P Neyroz; M Bonati
Journal:  Experientia       Date:  1985-03-15

2.  Protein binding of chloroquine in the presence of aspirin.

Authors:  S A Adelusi; L A Salako
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

3.  Dose-dependent inhibition of phosphoinositide metabolism in human platelets by aspirin in vitro and in vivo.

Authors:  P P Godfrey; F Bochner; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 4.  Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited.

Authors:  Daniella C N Hall; Ralf A Benndorf
Journal:  Cell Mol Life Sci       Date:  2022-07-02       Impact factor: 9.207

5.  Triazene drug metabolites: part 15. Synthesis and plasma hydrolysis of anticancer triazenes containing amino acid carriers.

Authors:  E Carvalho; J Iley; M J Perry; E Rosa
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

6.  Bioreversible derivatives of phenol. 1. The role of human serum albumin as related to the stability and binding properties of carbonate esters with fatty acid-like structures in aqueous solution and biological media.

Authors:  Jesper Østergaard; Claus Larsen
Journal:  Molecules       Date:  2007-10-30       Impact factor: 4.411

Review 7.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

8.  The initial inflammatory response to bioactive implants is characterized by NETosis.

Authors:  Ljubomir Vitkov; Wolf-Dietrich Krautgartner; Astrid Obermayer; Walter Stoiber; Matthias Hannig; Michaela Klappacher; Dominik Hartl
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 9.  Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.

Authors:  Argentina Ornelas; Niki Zacharias-Millward; David G Menter; Jennifer S Davis; Lenard Lichtenberger; David Hawke; Ernest Hawk; Eduardo Vilar; Pratip Bhattacharya; Steven Millward
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

10.  Rapid exposure of macrophages to drugs resolves four classes of effects on the leading edge sensory pseudopod: Non-perturbing, adaptive, disruptive, and activating.

Authors:  Thomas C Buckles; Brian P Ziemba; Danijel Djukovic; Joseph J Falke
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.